Table of Contents Author Guidelines Submit a Manuscript
International Journal of Chronic Diseases
Volume 2017 (2017), Article ID 8765804, 8 pages
https://doi.org/10.1155/2017/8765804
Research Article

The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana: A Cross-Sectional Study

1Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana
2Department of Molecular Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
3Department of Clinical Biochemistry, Diagnostic Directorate, Komfo Anokye Teaching Hospital, Kumasi, Ghana
4School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana
5Laboratory Department, Ho Municipal Hospital, Ghana Health Service, Ho, Volta Region, Ghana
6Diabetic Clinic, Ho Municipal Hospital, Ghana Health Service, Ho, Volta Region, Ghana

Correspondence should be addressed to James Osei-Yeboah; hg.ude.sahu@haobeyoj

Received 27 August 2016; Revised 20 January 2017; Accepted 24 January 2017; Published 12 February 2017

Academic Editor: Jochen G. Schneider

Copyright © 2017 James Osei-Yeboah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F.-V. K. Titty, W. K. B. A. Owiredu, and M. T. Agyei-Frempong, “Prevalence of metabolic syndrome and its individual components among diabetic patients in Ghana,” Journal of Biological Sciences, vol. 8, no. 6, pp. 1057–1061, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Akpalu, A. Akpalu, and F. Ofei, “The metabolic syndrome among patients with cardiovascular disease in Accra, Ghana,” Ghana Medical Journal, vol. 45, no. 4, pp. 161–166, 2011. View at Google Scholar · View at Scopus
  3. M. Gyakobo, A. G. B. Amoah, D.-A. Martey-Marbell, and R. C. Snow, “Prevalence of the metabolic syndrome in a rural population in Ghana,” BMC Endocrine Disorders, vol. 12, article no. 25, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Larkin, ““Metabolic syndrome” targeted in new US cholesterol guidelines,” The Lancet, vol. 357, no. 9268, p. 1594, 2001. View at Google Scholar · View at Scopus
  6. B. Isomaa, P. Almgren, T. Tuomi et al., “Cardiovascular morbidity and mortality associated with the metabolic syndrome,” Diabetes Care, vol. 24, no. 4, pp. 683–689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Grundy, “Metabolic syndrome pandemic,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 629–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. V. van Vliet-Ostaptchouk, M.-L. Nuotio, S. N. Slagter et al., “The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies,” BMC Endocrine Disorders, vol. 14, no. 1, article 9, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Xi, D. He, Y. Hu, and D. Zhou, “Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009,” Preventive Medicine, vol. 57, no. 6, pp. 867–871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Kow Nanse Arthur, M. Adu-Frimpong, J. Osei-Yeboah, F. Obu Mensah, and L. Owusu, “The prevalence of metabolic syndrome and its predominant components among pre-and postmenopausal Ghanaian women,” BMC Research Notes, vol. 6, no. 1, article no. 446, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Siva, S. Mythili, J. Rani, and P. S. Kumar, “Biochemical and haematological aberrations in type I and type II diabetic patients in South India-a comparative study,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 3, no. 2, pp. 967–977, 2012. View at Google Scholar
  12. C. Varım, T. Kaya, A. Nalbant, A. Uçar, and A. Tamer, “Effects of glucose control on hematological indices in patients with diabetes mellitus,” Macedonian Journal of Medical Sciences, vol. 7, no. 1, pp. 83–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Nsiah, V. Shang, K. Boateng, and F. Mensah, “Prevalence of metabolic syndrome in type 2 diabetes mellitus patients,” International Journal of Applied and Basic Medical Research, vol. 5, no. 2, p. 133, 2015. View at Publisher · View at Google Scholar
  14. J.-A. Shin, J.-H. Lee, S.-Y. Lim et al., “Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness,” Journal of Diabetes Investigation, vol. 4, no. 4, pp. 334–343, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. N. D. Wong, J. C. Nelson, T. Granston et al., “Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study,” JACC: Cardiovascular Imaging, vol. 5, no. 4, pp. 358–366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. P. Kengne, S. N. Limen, E. Sobngwi, C. F. T. Djouogo, and C. Nouedoui, “Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans,” Diabetology and Metabolic Syndrome, vol. 4, article 22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Mogre, Z. S. Salifu, and R. Abedandi, “Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus,” Journal of Diabetes and Metabolic Disorders, vol. 13, no. 1, article no. 80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Amidu, W. K. Owiredu, H. Alidu, C. Sarpong, C. K. Gyasi-Sarpong, and L. Quaye, “Association between metabolic syndrome and sexual dysfunction among men with clinically diagnosed diabetes,” Diabetology and Metabolic Syndrome, vol. 5, no. 1, article no. 42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. F.-V. K. Titty, “Glycaemic control, dyslipidaemia and metabolic syndrome among recently diagnosed diabetes mellitus patients in tamale teaching hospital, Ghana,” West African Journal of Medicine, vol. 29, no. 1, pp. 8–11, 2010. View at Google Scholar · View at Scopus
  20. W. Owiredu, N. Amidu, E. Gockah-Adapoe, and R. Ephraim, “The prevalence of metabolic syndrome among active sportsmen/sportswomen and sedentary workers in the Kumasi metropolis,” Journal of Science and Technology (Ghana), vol. 31, no. 1, 2011. View at Publisher · View at Google Scholar
  21. I. K. Owusu, C. Aryee, W. K. Owiredu, J. Osei-Yeboah, E. Owusu-Dabo, and E. F. Laing, “Analysis of atherogenic and anthropometric profiles of normotensive and hypertensive ghanaians in the kumasi metropolis,” British Journal of Medicine and Medical Research, vol. 7, no. 5, pp. 378–397, 2015. View at Publisher · View at Google Scholar
  22. M. Ruperto, G. Barril, and F. J. Sánchez-Muniz, “Conicity index as a contributor marker of inflammation in haemodialysis patients,” Nutricion Hospitalaria, vol. 28, no. 5, pp. 1688–1695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Vuga, “Conceptual review of issues with practical abdominal obesity measures,” in JSM Section on Statistics in Epidemiology, 2009. View at Google Scholar
  24. R. Lategan, V. L. Van den Berg, and C. M. Walsh, “Body adiposity indices are associated with hypertension in a black, urban Free State community: original research,” African Primary Health Care and Family Medicine, vol. 6, no. 1, pp. 1–7, 2014. View at Google Scholar
  25. C. M. Alexander, P. B. Landsman, S. M. Teutsch, and S. M. Haffner, “NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older,” Diabetes, vol. 52, no. 5, pp. 1210–1214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. E. S. Ford, “Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S.,” Diabetes Care, vol. 28, no. 11, pp. 2745–2749, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Ruan and Y. Guan, “Metabolic syndrome and chronic kidney disease,” Journal of Diabetes, vol. 1, no. 4, pp. 236–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Aguilar, T. Bhuket, S. Torres, B. Liu, and R. J. Wong, “Prevalence of the metabolic syndrome in the United States, 2003–2012,” JAMA, vol. 313, no. 19, pp. 1973–1974, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Puepet, A. Uloko, I. Akogu, and E. Aniekwensi, “Prevalence of the metabolic syndrome among patients with type 2 diabetes mellitus in urban North-Central Nigeria,” African Journal of Endocrinology and Metabolism, vol. 8, no. 1, 2009. View at Publisher · View at Google Scholar
  31. D. Akbar, “Metabolic syndrome is common in Saudi type 2 diabetic patients,” Hypertension, vol. 12, no. 2, pp. 47–49, 2002. View at Google Scholar
  32. O. Adediran, A. Edo, A. Jimoh, and A. Ohwovoriole, “Prevalence of the metabolic syndrome among Nigerians with type 2 diabetes,” Diabetes International, vol. 15, no. 1, pp. 13–14, 2007. View at Google Scholar
  33. E. S. Ford, W. H. Giles, and A. H. Mokdad, “Increasing prevalence of the metabolic syndrome among U.S. adults,” Diabetes Care, vol. 27, no. 10, pp. 2444–2449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Unadike, N. Akpan, E. Peters, I. Essien, and O. Essien, “Prevalence of the metabolic syndrome among patients with type 2 diabetes mellitus in Uyo, Nigeria,” African Journal of Endocrinology and Metabolism, vol. 8, no. 1, 2009. View at Publisher · View at Google Scholar
  35. L. W. Johnson and R. S. Weinstock, “The metabolic syndrome: concepts and controversy,” Mayo Clinic Proceedings, vol. 81, no. 12, pp. 1615–1620, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. G. T.-C. Ko, C. S. Cockram, C.-C. Chow et al., “High prevalence of metabolic syndrome in Hong Kong Chinese - Comparison of three diagnostic criteria,” Diabetes Research and Clinical Practice, vol. 69, no. 2, pp. 160–168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Kanter and B. Caballero, “Global gender disparities in obesity: a review,” Advances in Nutrition, vol. 3, no. 4, pp. 491–498, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. C. I. Okafor, “The metabolic syndrome in Africa: current trends,” Indian Journal of Endocrinology and Metabolism, vol. 16, no. 1, pp. 56–66, 2012. View at Publisher · View at Google Scholar
  39. H. N. Ginsberg and P. R. MacCallum, “The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus,” Journal of the CardioMetabolic Syndrome, vol. 4, no. 2, pp. 113–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Y. Gilani, S. Bibi, N. Ahmed, and S. R. Shah, “Gender differences of dyslipidemia in type 2 diabetics,” Journal of Ayub Medical College, Abbottabad : JAMC, vol. 22, no. 3, pp. 146–148, 2010. View at Google Scholar · View at Scopus
  41. R. Zhang, L. Zhao, L. Liang, G. Xie, and Y. Wu, “Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy,” Lipids in Health and Disease, vol. 11, article no. 59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. J. Robins, A. Lyass, J. P. Zachariah, J. M. Massaro, and R. S. Vasan, “Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the framingham heart study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 5, pp. 1208–1214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. J. D. Brunzell and J. E. Hokanson, “Dyslipidemia of central obesity and insulin resistance,” Diabetes Care, vol. 22, no. 3, pp. C10–C13, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. R. K. Avramoglu, H. Basciano, and K. Adeli, “Lipid and lipoprotein dysregulation in insulin resistant states,” Clinica Chimica Acta, vol. 368, no. 1-2, pp. 1–19, 2006. View at Publisher · View at Google Scholar · View at Scopus